Data from Eloxx’s proof-of-concept trial in patients with nonsense mutation Alport Syndrome (NMAS) presented in...
First two subjects dosed in Phase 1 clinical trial of ZKN-013; ZKN-013 is being developed for the potential...
Almirall obtains exclusive global rights to develop and commercialize ZKN-013 for the treatment of rare...
VANCOUVER, Wash. and BARCELONA, Spain, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a...
VANCOUVER, British Columbia, March 21, 2022 (GLOBE NEWSWIRE) -- Alliance Mining Corp. (TSXV:ALM) announced...
Klisyri has been approved for the treatment of actinic keratosis by the UK Medicines and Healthcare products...
REDWOOD CITY, Calif., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG), a pioneer in...
L'OCRCVM permet la reprise de la négociation - ALM; RHC Canada NewsWire VANCOUVER, le 17 oct. 2018 VANCOUVER, le 17 oct. 2018 /CNW/...
IIROC Trading Resumption - ALM; RHC Canada NewsWire VANCOUVER, Oct. 17, 2018 VANCOUVER, Oct. 17, 2018 /CNW/ - Trading resumes in: Company:...
Suspension de la négociation par l'OCRCVM - ALM Canada NewsWire VANCOUVER, le 15 oct. 2018 VANCOUVER, le 15 oct. 2018 /CNW/ - L'OCRCVM a...
IIROC Trading Halt - ALM Canada NewsWire VANCOUVER, Oct. 15, 2018 VANCOUVER, Oct. 15, 2018 /CNW/ - The following issues have been halted by...
L'OCRCVM permet la reprise de la négociation - ALM Canada NewsWire VANCOUVER, le 24 août 2018 VANCOUVER, le 24 août 2018 /CNW/...
IIROC Trading Resumption - ALM Canada NewsWire VANCOUVER, Aug. 24, 2018 VANCOUVER, Aug. 24, 2018 /CNW/ - Trading resumes in: Company: Alliance...
Suspension de la négociation par l'OCRCVM - ALM Canada NewsWire VANCOUVER, le 23 août 2018 VANCOUVER, le 23 août 2018 /CNW/ - L'OCRCVM...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads